Skip to main content
Clinical Trials/JPRN-UMIN000013881
JPRN-UMIN000013881
Not yet recruiting
Phase 2

Phase II Study to evaluate efficacy and safety of Lenalidomide maintenance therapy for multiple myeloma patients under bortezomib treatment - L-Defense study

ational Defense Medical College0 sites29 target enrollmentMay 5, 2014

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
multiple myeloma
Sponsor
ational Defense Medical College
Enrollment
29
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 5, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Defense Medical College

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients who are pregnant or lactating. 2\. Patients who had been determined ineligible for any reason by physician. 3\. Patients who have not achieved PR with bortezomib therapy as initial treatment. 4\. Patients who progressed in disease status less than PR after the initial response.

Outcomes

Primary Outcomes

Not specified

Similar Trials